Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Fierce Pharma
Tue, 03/14/23 - 06:21 pm
vaccines
GSK
Pfizer
meningococcal disease
Menveo
Bexsero
In busy year with Haleon spinoff and Zantac lawsuits, GSK CEO Emma Walmsley scored slight pay raise
Fierce Pharma
Mon, 03/13/23 - 10:06 am
GSK
Pharma CEOs
Emma Walmsley
executive pay
Pfizer ready to launch RSV vaccines for older adults, pregnant women in US, Europe
Reuters
Fri, 03/10/23 - 09:51 am
Pfizer
GSK
vaccines
RSV
Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab?
Yahoo/Zacks.com
Wed, 03/8/23 - 09:30 am
GSK
Pfizer
FDA
vaccines
RSV
FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks
CNBC
Wed, 03/1/23 - 06:56 pm
GSK
RSV
vaccines
FDA
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
CROI 2023 – GSK and Gilead’s long-acting HIV battle intensifies
EP Vantage
Mon, 02/27/23 - 07:01 pm
GSK
Gilead Sciences
CROI
Cabenuva
HIV
GSK's bellwether Zantac court date pushed to July
Endpoints
Sun, 02/26/23 - 10:11 pm
GSK
Zantac
legal
bladder cancer
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo/Reuters
Fri, 02/24/23 - 09:08 am
GSK
HIV
ViiV Healthcare
Gilead Sciences
Cabenuva
Biktarvy
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Pfizer
RSV
vaccines
GSK
AstraZeneca
Sanofi
RSVpreF
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
'It's the right call': GSK expresses no regrets on abandoning cell therapy as oligo strategy heats up
Fierce Biotech
Fri, 02/17/23 - 09:46 am
GSK
cell therapy
gene therapy
oligonucleotides
Wave Life Sciences
GSK vaccine R&D head touts consistency of RSV data but is mum on restarting maternal trial
Fierce Biotech
Thu, 02/16/23 - 10:16 am
GSK
R&D
RSV
vaccines
FDA
GSK was warned repeatedly about Zantac impurity but played down risks
Fierce Pharma
Wed, 02/15/23 - 06:09 pm
GSK
Zantac
FDA
cancer
GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners
Fierce Biotech
Tue, 02/14/23 - 11:02 am
GSK
Vir Biotechnology
COVID-19
vaccines
Pfizer begins plan to challenge Shingrix with an mRNA vaccine
BioPharma Dive
Sun, 02/12/23 - 07:38 pm
Pfizer
MRNA
GSK
shingles
vaccines
Shingrix
BioNTech
GSK's unusual Jemperli expansion plan wins FDA panel backing—with a twist
Fierce Pharma
Fri, 02/10/23 - 11:21 am
GSK
rectal cancer
Jemerpli
FDA
Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds
Fierce Pharma
Thu, 02/9/23 - 06:05 pm
GSK
physicians
anemia
Jesduvroq
FDA assembles adcomm to review GSK's Jemperli trial plans in rectal cancer
Endpoints
Tue, 02/7/23 - 06:50 pm
FDA
GSK
rectal cancer
Jemperli
GSK's retrospective trial diversity study shows there's more work to do
Fierce Biotech
Mon, 02/6/23 - 06:18 pm
GSK
clinical trials
clinical trial diversity
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »